Leverage Anonymized Patient Level Data (APLD) to Identify Market Opportunities
How can you use patient level data to help rebound from a sluggish product launch? Our client, a growing specialty pharmaceutical company, has a new product approved for treating two different diseases. After a year on the market, however, the new drug’s uptake is...
Real World Evidence to Support Payer Negotiation
How do you prove a product’s value to negotiate pricing with a payer? Our client, a large global pharmaceutical company, was facing a market access problem for their newly launched product. Generic treatments have been widely available for many years in this...
Sales Force Effectiveness for Top 20 Pharma
Taking a holistic view in evaluating and revamping sales force effectiveness can have a significant impact on the overall health of multi-national pharmaceutical company. Our client, a large global pharmaceutical was facing a range of outside stressors with regard to...
IC Plan Design in Defense of Competitive Entry
Using IC to optimize sales force behavior and generate sales success. Addressing a client’s incentive compensation (IC) plan and implementation can have a significant and immediate impact on changing sales force behavior when priorities shift. In this particular case,...
